FDA Approves First Drug to Treat Severe Multiple Sclerosis – New York Times

Posted: Published on March 28th, 2017

This post was added by Dr Simmons


New York Times
FDA Approves First Drug to Treat Severe Multiple Sclerosis
New York Times
The Food and Drug Administration approved on Tuesday the first drug to treat a severe form of multiple sclerosis, offering hope to patients who previously had no other options to combat a relentless disease that leads to paralysis and cognitive decline.
FDA Approves Ocrevus as 1st MS Treatment for Both Relapsing and Primary Progressive FormsMultiple Sclerosis News Today
After 40-year odyssey, first drug for aggressive MS wins FDA approvalSTAT
Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp BiogenTheStreet.com
Reuters -BioPharma Dive
all 16 news articles »

Read more:
FDA Approves First Drug to Treat Severe Multiple Sclerosis - New York Times

Related Posts
This entry was posted in MS Treatment. Bookmark the permalink.

Comments are closed.